Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 San Antonio Breast Cancer Symposium
| TNBIX Fund | USD 20.11 0.12 0.60% |
Slightly above 52% of 1290 Smartbeta's investor base is interested to short. The analysis of overall sentiment of trading 1290 Smartbeta Equity mutual fund suggests that many investors are impartial at this time. 1290 Smartbeta's investing sentiment can be driven by a variety of factors including economic data, 1290 Smartbeta's earnings reports, geopolitical events, and overall market trends.
1290 |
NEW HAVEN, Conn., Nov. 25, 2024 -- Arvinas, Inc. today announced that three posters for vepdegestrant, including clinical data, will be presented at the 2024 San Antonio Breast Cancer Symposium , being held December 10-13, 2024, in San Antonio, Texas. Vepdegestrant is a novel investigational PROTAC estrogen receptor degrader that is being jointly developed by Arvinas and Pfizer for the treatment of patients with early and locally advanced or metastatic
Read at finance.yahoo.com
 |
1290 Smartbeta Fundamental Analysis
We analyze 1290 Smartbeta's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 1290 Smartbeta using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 1290 Smartbeta based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
1290 Smartbeta is currently under evaluation in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
1290 Smartbeta Equity Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 1290 Smartbeta mutual fund to make a market-neutral strategy. Peer analysis of 1290 Smartbeta could also be used in its relative valuation, which is a method of valuing 1290 Smartbeta by comparing valuation metrics with similar companies.
Peers
1290 Smartbeta Related Equities
| ESCKX | 1290 Funds | 0.96 | ||||
| TNBAX | 1290 Smartbeta | 0.60 | ||||
| TNBRX | 1290 Smartbeta | 0.55 | ||||
| TNIIX | 1290 Retirement | 0.45 | ||||
| TNBCX | 1290 Smartbeta | 0.00 | ||||
| ESCFX | 1290 Funds | 0.00 | ||||
| ESCJX | 1290 Essex | 0.07 | ||||
| TNHIX | 1290 High | 0.35 | ||||
| TNHAX | 1290 High | 0.35 |
Other Information on Investing in 1290 Mutual Fund
1290 Smartbeta financial ratios help investors to determine whether 1290 Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 1290 with respect to the benefits of owning 1290 Smartbeta security.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |